18.07.2012
- Large investors in U.S. biotech companies are likely to capture serious windfall profits as deal activity picks up in the sector. A Reuters analysis of investors' average cost...
14.06.2012
- Competition in the eye drug market is heating up, with an experimental drug from private U.S. biotech Ophthotech showing impressive results when added to Roche's Lucentis in a...
